Market Cap | ₹136Cr |
ROE | 9.32% |
P/E Ratio(TTM) | 19.05 |
EPS(TTM) | 4.50 |
P/B Ratio | 1.76 |
Dividend Yield | 1.40% |
Industry P/E | 35.77 |
Book Value | 48.63 |
Debt to Equity | 1.94 |
Face Value | 10 |
Parent Organisation | Bal Pharma |
Managing Director | Shailesh Siroya |
NSE Symbol | BALPHARMA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 103.18 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
Wockhardt | NA (0.00%) | -195.86 |